Upcoming Webinar - Developing and Optimizing Cell-based Microplate Assays

Ortenberg, (PresseBox) - Looking to perform a microplate cell-based assay for the first time or would like to develop a higher throughput for your current cell-based assay? On November 28th at noon EST a webinar will be hosted by Drug Discovery and Development and BMG LABTECH, the Microplate Reader Company, to discuss developing and optimizing cell-based assays in a microplate format.

Many researchers look to translate their biochemical microplate assay to a cell-based format because biochemical assays can be limiting and misleading in the information that they provide. This growing trend has caused a surge in the development of many new cell-based microplate assays, as well as new developments in the instrumentation used to optimize these cell-based microplate assays.

In this webinar, three speakers will present some of the different aspects involved in developing and optimizing cell-based assays in a microplate format. Please join us to learn more about:

- Optimizing Measurements for Microplate Cell-based Assays; Catherine Wark, BMG LABTECH, UK
- Miniaturization and Automation of HTRF® Cell-based Assays with the Echo® Liquid Handler; Bonnie Edwards, Labcyte, Inc., USA
- Identification and characterization of allosteric modulators of GPCRs using an HTRF® cellular assay; Jeff Jerman, PhD, MRC Technology, UK

Join us on: Wednesday, November 28th at 12:00 EST. Participation in this webinar is free and we look forward to you joining us. For more information visit: http://www.bmglabtech.com/webinar/cell-based-assays.cfm.

Press releases you might also be interested in

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.


I want to subscribe to the gratis press mail and have read and accepted the conditions.